Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis

OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis OSTEOARTHRITIS AND CARTILAGE Gold, G. E., Cicuttini, F., Crema, M. D., Eckstein, F., Guermazi, A., Kijowski, R., Link, T. M., Maheu, E., Martel-Pelletier, J., Miller, C. G., Pelletier, J., Peterfy, C. G., Potter, H. G., Roemer, F. W., Hunter, D. J. 2015; 23 (5): 716-731

Abstract

Imaging of hip in osteoarthritis (OA) has seen considerable progress in the past decade, with the introduction of new techniques that may be more sensitive to structural disease changes. The purpose of this expert opinion, consensus driven recommendation is to provide detail on how to apply hip imaging in disease modifying clinical trials. It includes information on acquisition methods/techniques (including guidance on positioning for radiography, sequence/protocol recommendations/hardware for magnetic resonance imaging (MRI)); commonly encountered problems (including positioning, hardware and coil failures, artifacts associated with various MRI sequences); quality assurance/control procedures; measurement methods; measurement performance (reliability, responsiveness, and validity); recommendations for trials; and research recommendations.

View details for DOI 10.1016/j.joca.2015.03.004

View details for Web of Science ID 000353821200006

View details for PubMedID 25952344

View details for PubMedCentralID PMC4430132